TP53 and non-small cell lung carcinoma: Another study (11) revealed that circSCAP directly binds to SF3A3 and facilitates its degradation, leading to elevated MDM4S levels that activate p53 signaling, thereby suppressing the occurrence and metastasis of NSCLC.